Skip to content

MDMA: all studies

Page 83 of 347: studies 821 to 830 of 3,461, newest first. Back to the MDMA overview

Research

Protective effects of physical exercise on MDMA-induced cognitive and mitochondrial impairment.

Free radical biology & medicine October 2016 Ghorban Taghizadeh, Jalal Pourahmad, Hajar Mehdizadeh et al.

Debate continues about the effect of 3, 4-methylenedioxymethamphetamine (MDMA) on cognitive and mitochondrial function through the CNS. It has been shown that physical exercise has an important protective effect on cellular damage and death. Therefore, we investigated the effect of physical exercise on MDMA-induced impairments of spatial learning and memory as well as MDMA effects on brain...

DOI: 10.1016/j.freeradbiomed.2016.07.018 (opens in new tab) Full text (opens in new tab) 3, 4-Methylenedioxymethamphetamine MDMA Cytochrome c Learning and memory Mitochondria +3

Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.

Substance Use & Misuse September 23, 2016 Joseph J Palamar, Patricia Acosta, Danielle C Ompad et al.

Background: Ecstasy (MDMA) use has regained popularity in the United States, particularly in the form of "Molly," which is often marketed as pure MDMA. Surveys have generally not included "Molly" in the definition of ecstasy, so rates of use may be underestimated. As popularity of ecstasy increases, research is needed to examine use among those at highest risk for use-nightlife attendees....

Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.

Naunyn-Schmiedeberg's Archives of Pharmacology September 20, 2016 Jakob A. Shimshoni, Ilan Winkler, Ezekiel Golan et al. 23 citations

3,4-Methylenedioxy-N-methylamphetamine (MDMA) has been shown to be effective in the treatment of post-traumatic stress disorder (PTSD) in numerous clinical trials. In the present study, we have characterized the neurochemical binding profiles of three MDMA-benzofuran analogues (1-(benzofuran-5-yl)-propan-2-amine, 5-APB; 1-(benzofuran-6-yl)-N-methylpropan-2-amine, 6-MAPB;...

DOI: 10.1007/s00210-016-1297-4 (opens in new tab) Novel compounds Indole analogues Benzofuran analogues New compounds +29

The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux

Biochemical Pharmacology September 13, 2016 Natalie R Sealover, Bruce Felts, Charles P. Kuntz et al.

The substituted amphetamine, 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy), is a widely used drug of abuse that induces non-exocytotic release of serotonin, dopamine, and norepinephrine through their cognate transporters as well as blocking the reuptake of neurotransmitter by the same transporters. The resulting dramatic increase in volume transmission and signal duration of...

Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use

Journal of Psychopharmacology September 6, 2016 Helle Ruff Laursen, Susanne Henningsson, Julian Macoveanu et al. 8 citations

The brain’s serotonergic system plays a crucial role in the processing of emotional stimuli, and several studies have shown that a reduced serotonergic neurotransmission is associated with an increase in amygdala activity during emotional face processing. Prolonged recreational use of ecstasy (3,4-methylene-dioxymethamphetamine [MDMA]) induces alterations in serotonergic neurotransmission that...

Serotonin antagonists fail to alter MDMA self-administration in rats.

Pharmacology, Biochemistry, and Behavior September 2016 Susan Schenk, Jason Foote, Dane Aronsen et al.

Acute exposure to ±3,4-methylenedioxymethamphetamine (MDMA) preferentially increases release of serotonin (5-HT), and a role of 5-HT in many of the behavioral effects of acute exposure to MDMA has been demonstrated. A role of 5-HT in MDMA self-administration in rats has not, however, been adequately determined. Therefore, the present study measured the effect of pharmacological manipulation of...

DOI: 10.1016/j.pbb.2016.06.002 (opens in new tab) Full text (opens in new tab) MDMA Hyperactivity Reinstatement Self-administration +1

[Hyponatremia-induced life-threatening cerebral edema after ecstasy use].

Medizinische Klinik, Intensivmedizin und Notfallmedizin September 2016 S Baumann, T Becher, D Frambach et al.

Ecstasy, a psychoactive amphetamine derivative, is a popular party drug. We report the cases of 2 young adults who developed cerebral edema due to hyponatremia. One patient was released from the hospital without any sequelae, whereas the second patient died due to cerebral edema. Severe cases of symptomatic hyponatremia after ecstasy consumption are described in the literature with partially...

Between ecstasy and reason: a symbolic interpretation of UDV trance

September 1, 2016 Rosa Virgínia Melo 2 citations

Introduction The following discussion takes up symbolic elaborations of myth and ritual as expressive channels for institutional meanings activated by the psychoactive sacrament used in the União do Vegetal (UDV), an ayahuasca religion born in Brazilian Amazonia. Called vegetal or hoasca, the decoction is prepared with the leaf of Psychotria viridis and the vine Banisteriopsis caapi, which...

DOI: 10.4324/9781315551425-9 (opens in new tab) Ecstasy Trance Interpretation philosophy Cognitive psychology +2

B-56Investigation of Personality Change Following MDMA-Assisted Psychotherapy for Post Traumatic Stress Disorder

Archives of Clinical Neuropsychology August 31, 2016 Michael Wagner, Michael C Mithoefer, Ann T Mithoefer et al. 1 citation

Objective: New data from a previously published randomized blinded Phase II clinical trial (Mithoefer, et al., 2011) is presented here to test whether psychological change mediates the effect of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment-resistant PTSD. Method: Twenty-three (23) subjects with treatment-refractory PTSD were randomized to either a...

Identification and characterization of N‐tert‐butoxycarbonyl‐MDMA: a new MDMA precursor

Drug Testing and Analysis August 30, 2016 Michael P Collins, Christopher Donnelly, Shane Cameron et al. 21 citations

In September 2015, 80 litres of a viscous, light‐red liquid, described as hair product, was seized by the Australian Border Force (ABF). Initial testing by ABF indicated that the liquid was the 3,4‐methylenedioxymethamphetamine (MDMA) precursor chemical safrole and custody of the material was transferred to the Australian Federal Police (AFP) who coordinated all subsequent investigations....